Table 2: Summary of findings for primary and secondary outcomes.
|
N |
Outcomes |
Trials |
n |
I2 (%) |
Effect model |
MD/OR (95% CI) |
p-value |
|
1 |
Discharge |
5 |
1505 |
82 |
REM |
-0.09 [-1.11, 0.93] |
0.86 |
|
2 |
Injection pain |
5 |
1505 |
63 |
REM |
0.11 [0.05, 0.22] |
< 0.00001 |
|
3 |
Fully alert |
4 |
1293 |
83 |
REM |
-3.09 [-38.16, 31.98] |
0.86 |
|
4 |
Induction time |
5 |
1505 |
96 |
REM |
21.31 [9.95, 32.67] |
0.0002 |
|
5 |
Hypotension |
5 |
1505 |
67 |
REM |
0.40 [0.26, 0.63] |
<0.0001 |
|
6 |
Adverse events |
3 |
1125 |
56 |
REM |
0.53 [0.34, 0.83] |
0.006 |
I2: Heterogeneity; MD: Mean Difference; OR: Odds Ratio; REM: Random Effect Model; CI: Confidence Interval